Board Meeting5 Nov 2026, 12:52 pm
Symbiox Investment Board Meeting on Nov 13 to Approve Q2 Results
AI Summary
Symbiox Investment & Trading Company Ltd has announced that its Board of Directors meeting is scheduled for November 13, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended September 30, 2026. Additionally, the board will review the limited review report on these financial results. The meeting will commence at 01:30 PM at the company's registered office.
Key Highlights
- Board meeting scheduled for November 13, 2026.
- To approve unaudited financial results for Q2 FY27.
- Limited review report on financial results to be considered.
- Meeting to be held at the registered office.
- Standard agenda item for financial reporting.
Price Impact
More from SYMBIOX